Targeting the pathophysiology of diabetic macular edema

Diabetes Care. 2010 Nov;33(11):2484-5. doi: 10.2337/dc10-1580.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Diabetic Retinopathy / drug therapy*
  • Female
  • Humans
  • Macular Edema / drug therapy*
  • Male
  • Middle Aged
  • Ranibizumab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Ranibizumab